We are live on ! Find out more
ICP

Interchange Capital Partners Portfolio holdings

AUM $317M
1-Year Est. Return 12.76%
This Fund
S&P 500
This Quarter Est. Return
+6.15%
1 Year Est. Return
+12.76%
3 Year Est. Return
+53.83%
5 Year Est. Return
+55.21%
10 Year Est. Return
AUM
$131M
AUM Growth
-$53.3M
Cap. Flow
-$60.2M
Cap. Flow %
-45.98%
Top 10 Hldgs %
36.12%
Holding
239
New
17
Increased
45
Reduced
86
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 11.26%
2 Healthcare 5.11%
3 Consumer Discretionary 4.06%
4 Communication Services 3.82%
5 Financials 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
76
Merck
MRK
$315B
$419K 0.32%
3,630
-7,616
-68% -$865K
PATH icon
77
UiPath
PATH
$6.3B
$417K 0.32%
24,997
+13,452
+117% +$216K
SCHF icon
78
Schwab International Equity ETF
SCHF
$65.4B
$395K 0.3%
22,164
+20
+0.1% +$355
HDV
79
iShares Core High Dividend ETF
HDV
$14.2B
$389K 0.3%
19,295
-340
-2% -$6.84K
COST icon
80
Costco
COST
$417B
$388K 0.3%
721
+36
+5% +$18.2K
KLAC icon
81
KLA
KLAC
$278B
$384K 0.29%
7,600
-3,280
-30% -$137K
PEP icon
82
PepsiCo
PEP
$187B
$382K 0.29%
2,063
-9,738
-83% -$1.82M
BAC icon
83
Bank of America
BAC
$430B
$375K 0.29%
13,062
-3,678
-22% -$105K
DIS icon
84
Walt Disney
DIS
$170B
$371K 0.28%
4,143
-1,025
-20% -$97.1K
MA icon
85
Mastercard
MA
$480B
$366K 0.28%
931
-567
-38% -$213K
CVX icon
86
Chevron
CVX
$373B
$365K 0.28%
2,312
-565
-20% -$90.6K
NTLA icon
87
Intellia Therapeutics
NTLA
$1.59B
$363K 0.28%
8,899
-3,129
-26% -$127K
U icon
88
Unity
U
$12.7B
$362K 0.28%
+8,325
New +$267K
IYG icon
89
iShares US Financial Services ETF
IYG
$2.06B
$357K 0.27%
7,098
-99
-1% -$5.02K
USFR icon
90
WisdomTree Floating Rate Treasury Fund
USFR
$17.9B
$356K 0.27%
7,068
+2,104
+42% +$106K
INTU icon
91
Intuit
INTU
$79.6B
$355K 0.27%
775
+87
+13% +$38.1K
RTX icon
92
RTX Corp
RTX
$261B
$355K 0.27%
3,617
-1,366
-27% -$134K
TMO icon
93
Thermo Fisher Scientific
TMO
$198B
$355K 0.27%
679
-404
-37% -$218K
DVY icon
94
iShares Select Dividend ETF
DVY
$23.8B
$354K 0.27%
3,127
-363
-10% -$41.4K
AMGN icon
95
Amgen
AMGN
$198B
$339K 0.26%
1,522
-2,132
-58% -$495K
DKNG icon
96
DraftKings
DKNG
$12.4B
$333K 0.25%
+12,625
New +$291K
PG icon
97
Procter & Gamble
PG
$349B
$330K 0.25%
2,168
+119
+6% +$17.9K
TDOC icon
98
Teladoc Health
TDOC
$1.7B
$324K 0.25%
+12,321
New +$310K
CRSP icon
99
CRISPR Therapeutics
CRSP
$4.71B
$323K 0.25%
5,435
+607
+13% +$34.4K
CSX icon
100
CSX Corp
CSX
$94.3B
$321K 0.25%
9,417
-112
-1% -$3.54K

Similar funds

Interchange Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Interchange Capital Partners held 239 positions worth $131M, down 29% from $184M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Interchange Capital Partners withdrew a net $60.2M in Q2 2023, closing 91 positions and reducing 86 holdings. Its most notable exit was JPMorgan Ultra-Short Municipal Income ETF, an estimated $4.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Interchange Capital Partners opened a new position in Invesco S&P 500 Equal Weight Technology ETF worth $527K.

  • Interchange Capital Partners's largest Q2 2023 buy was Invesco S&P 500 Equal Weight Technology ETF: 17,930 shares worth $527K.
  • Interchange Capital Partners added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.33M increase.
  • Interchange Capital Partners's biggest Q2 2023 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $5.8M.
  • Interchange Capital Partners fully exited JPMorgan Ultra-Short Municipal Income ETF in Q2 2023, selling an estimated $4.82M.
  • Interchange Capital Partners's ten largest holdings make up 36% of its $131M portfolio in Q2 2023.
  • Interchange Capital Partners opened 17 new positions and closed 91 in Q2 2023.
  • Interchange Capital Partners's portfolio value fell 29% quarter-over-quarter to $131M.

Based on Interchange Capital Partners's 13F filing for Q2 2023, filed 8 Aug 2023.